metformin has been researched along with lysophosphatidylcholines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Huo, T; Li, F; Li, N; Xiong, Z | 1 |
| Fu, JF; Huang, Y; Liu, LR; Shi, HB | 1 |
2 other study(ies) available for metformin and lysophosphatidylcholines
| Article | Year |
|---|---|
Lysophosphatidylcholine--biomarker of Metformin action: studied using UPLC/MS/MS.
Topics: Adult; Biomarkers; Chromatography, High Pressure Liquid; Humans; Lysophosphatidylcholines; Male; Metformin; Multivariate Analysis; Principal Component Analysis; Tandem Mass Spectrometry | 2009 |
[Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Topics: Animals; Apoptosis; Disease Models, Animal; Down-Regulation; Fatty Liver; Insulin Resistance; Lipid Metabolism; Lysophosphatidylcholines; Male; Metformin; Non-alcoholic Fatty Liver Disease; Phospholipases A2; Rats; Rats, Sprague-Dawley; Signal Transduction | 2011 |